Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Joint cartilage lubrication" refers to the ensemble of *biological and mechanical mechanisms* by which synovial joints achieve ultralow friction, essential for pain-free and efficient movement. Articular cartilage lubrication is not mediated by a single protein, receptor, or enzyme, but rather by the synergistic action of several macromolecules found in both cartilage and synovial fluid, including **hyaluronic acid (hyaluronan)**, **lubricin (PRG4)**, **phospholipids (mainly phosphatidylcholine-containing lipids)**, and **proteoglycans** such as **aggrecan**[1][2][3][5]. These molecules organize into complex boundary layers and/or fluid films at cartilage surfaces: - **Hyaluronic acid**: a large, negatively charged polysaccharide, forms the backbone for proteoglycan aggregation and interacts with lubricin[1][2]. - **Lubricin (PRG4)**: a glycoprotein crucial for boundary lubrication, binds to cartilage surfaces and HA, preventing adhesion and wear[1][2][3]. - **Phospholipids**: contribute to boundary lubrication by forming hydrated layers and interacting with hyaluronic acid[1]. - **Proteoglycans**: such as aggrecan, entrap and retain water, supporting the biphasic (solid-liquid) matrix that underlies hydrodynamic lubrication[1][5]. Lubrication mechanisms include **fluid film lubrication** (where interstitial and synovial fluid form a separating film), **boundary lubrication** (where molecules like lubricin and phospholipids prevent direct cartilage contact), **hydration lubrication** (where hydration shells on charged molecules provide low friction), as well as **weeping** and **squeezing** lubrication, where fluid is exuded from cartilage under pressure to maintain lubrication[1][2][3][5]. Therefore, "joint cartilage lubrication" is a **biomechanical and biochemical process**, not a molecular target, and should not be treated as a canonical receptor, enzyme, or protein. Any molecular targeting for therapeutic purposes in this context would be directed at *individual macromolecules* involved in this process such as hyaluronic acid, lubricin/PRG4, or their specific receptors, not the process itself[2][5]. In summary, "joint cartilage lubrication" is conceptually important for joint health and osteoarthritis, but it is not a canonical molecular target; instead, it represents the collective action of molecules and physical processes required for healthy joint function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Joint cartilage lubrication.